Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Finallytherock

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Mar 04, 2022 5:53pm

91 Views

Post# 34485309

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Finallytherock

So beenthere is going to compete with me as a victim, 39 years as a contracted engineer. Ok, so you're a victim, beenthere. I'm not a victim. I've chosen to stay for all the reasons I posted earlier. I'm already moving into other areas.

A budget, beenthere? Me too. I had to tap into savings, which were what I budgeted for. So I agree, budgets are good.

Let me sum it up. I lost both savings and income on Bioasis. The loss of income forced me to lock down my Bioasis stock losses. Don't be whining to me about 10 years. Do I have the same chance of gaining back my losses as shareholders have? I guess we'll see.

jd

<< Previous

Bullboard Posts

Next >>

New glaucoma treatment studied in a $3.4 billion market